It has been established that mesothelioma patients that exhibit progressive disease have high serum levels of survivin, yet the application and efficacy of survivin small molecule inhibitors (e.g., YM155) as a potential treatment for MPM remains to be explored [33]. The gene discussed is BIRC5; the disease is mesothelioma.